NCT03277079

Low Dose Statins, Ezetimibe and Nutraceuticals

Low Dose Statins, Ezetimibe and Nutraceuticals in Coronary Artery Disease Patients Intolerant to High Intensity Statin Treatment (TArget ChOlesterol)

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 100 (estimated)
• Sponsor: University of Roma La Sapienza · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

It remains unknown if the association between moderate to low intensity statin therapy and ezetimibe and nutraceuticals might have a therapeutic role in high-intensity statin intolerant patients

Detailed description

The aim of this study will be to evaluate whether the association between statin and exetimibe vs statin + ezetimibe + nutraceuticals can lead to higher percentage of LDL target achievement

Conditions

• Coronary Artery Disease

Interventions

Type	Name	Description
DRUG	statin + ezetimibe	Combination of two drugs
DRUG	statin + ezetimibe + Nutraceuticals	Combination of two grus plus nutraceuticals

Timeline

• Start date: 2017-10-01
• Primary completion: 2017-12-31
• Completion: 2018-03-31
• First posted: 2017-09-08
• Last updated: 2017-09-08

Locations

1 site across 1 country: Italy